Remgro upside still on the box of cards - R191.31Box formation formed on Remgro.
Now this is an update to show the upside that's on the way, and what is to come.
As a short term trader one can set the target at R169.00.
As a medium term trader one can set the target to R191.00.
All depends on the R:R placement method and term to hold.
Either way, this thing is heading up.
MAs - 7>21>200
RSI>50
Target R191.31
ABOUT THE COMPANY
Remgro Limited is an investment holding company based in South Africa. Remgro is a prominent investment holding company based in Stellenbosch, South Africa.
Establishment:
Remgro was incorporated in 1948 in South Africa as a tobacco manufacturer. originally part of the wider Rembrandt Group founded by Dr. Anton Rupert.
Name Origin:
The name "Remgro" is derived from "Rembrandt Group", the original tobacco company from which Remgro split in the 1980s.
Investment Focus:
The company focuses on a broad spectrum of industries, including banking, healthcare, insurance, industrial, infrastructure, media, sport and recreation, technology, and consumer sectors.
Headquarters:
Remgro's headquarters are located in Stellenbosch, South Africa.
Major Investments:
Remgro holds major stakes in numerous well-known South African companies such as RMB Holdings, FirstRand, MediClinic, and Distell.
Mediclinic Corporation:
In the healthcare sector, Remgro holds a significant stake in Mediclinic Corporation, an international private hospital group.
Sports Investment:
Remgro owns a controlling interest in the Stellenbosch Rugby Academy.
HOW IT GOT ITS NAME
Remgro, short for Rembrandt Group Limited, gets its name from the larger conglomerate it was part of, the Rembrandt Group, which was founded by Dr. Anton Rupert in the 1940s.
The name "Rembrandt" was likely chosen as a nod to the famous Dutch painter, Rembrandt Harmenszoon van Rijn, reflecting the Dutch heritage of the Rupert family. When the Rembrandt Group restructured in the 1980s and 2000s, the investment arm became known as Remgro.
REM
Remgro Double Top TargetRemgro Ltd. is an investment holding company established with effect from 1 April 2000, after the restructuring of the former Rembrandt Group Ltd. The Group's interests consist mainly of investments in consumer products; banking; healthcare; insurance; industrial; infrastructure as well as media and sport. The company's activities are concentrated mainly on the management of investments and the provision of support rather than on being involved in the day-to-day management of business units of investees. Subsidiaries not wholly owned include listed companies with independent boards of directors on which this company has non-executive representation. Non-subsidiary investments comprise both listed and unlisted companies not controlled by this company and which are mostly associated companies due to significant influence and board representation.
Technicals
This bullish correction has completed 5 waves which usually means there will be a break to the upside now. It's unusual but sometimes corrective structures form a 6th wave as well so I will still be careful of a reversal when price reaches the top of the structure. A break of the structure currently has a target exactly at the previous high. Smaller time frames will give an entry for the long.
Happy trading!
Linton
DSKX Begins To Rally After The Conference CallShares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products.
It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company, so if you haven't already, I highly encourage you to listen to today's conference call as soon as possible. Much larger company structure overall, significant increase in revenue, assets, cash flow and working capital with a very reputable management team to move the company forward. The fact that the current market cap is only 33M is what really gets me excited. Listen to the call to learn more:
The replay of the conference call can be heard by dialing 1-888-286-8010 in the United States and Canada or +1-617-801-6888 internationally, then referencing the Conference Passcode "56187013" A recording of the call can also be heard on the company website.
In the call, the DS Healthcare Group management team shared their motivations and answered questions relating to the business fundamentals on the Radiancy & Neova® deal, explaining how natural strategy alignment and synergies will lead to significant bottom line contribution.
The call was hosted by Mark Brockelman (CFO), Manny Gonzeles (CCO) and Renee Barch-Niles (CEO) and took place on Thursday, February 25th, 2016, at 8:30 a.m. EST.
-Renee Barch-Niles (CEO), an experienced CPG Executive who drove double-digit year-over-year growth in global food, drug, mass, club and specialty channels for Global companies such as Daymon Worldwide and Emilia Personal Care.
-Mark Brockelman (CFO) who has great experience in mergers and acquisitions, systems integration expertise and highly astute financial acumen. Mr. Brockelman Brockelman served as the Chief Financial Officer for National Dentex Corporation as well as the Senior Vice President/Chief Financial and Administrative Officer of the Miami Dolphins.
-Manny Gonzalez (CCO), a former top (NASDAQ: PG) Procter & Gamble executive managing a team of 7,000 sales representatives in the U.S., who has direct access to every major retailer in the country.
Acquisition Press Release Below:
finance.yahoo.com
For full disclose please visit: www.stockpicksnyc.com